PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspoliomyelitis
MeSH D011051 - poliomyelitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009468:Neuromuscular diseases
1 Company
1 Drug
$
Success rate
D009187:Myelitis
0 Companies
0 Drugs
Success rate
D004769:Enterovirus infections
0 Companies
0 Drugs
Success rate
D011051: 
Poliomyelitis
3 Companies
0 Drugs
Success rate
D011052:Bulbar poliomyelitis
0 Companies
0 Drugs
Success rate
D016262:Postpoliomyelitis syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Ademetionine,
Edetic acid,
Synflorix,
Fendrix,
Fluzone,
Prevenar13,
Prevnar13,
Menactra,
Pneumovax,
Ipv,
Repevax,
Flumist,
Flucelvax,
Prevenar
Sanofi
Ademetionine,
Bevifimod,
Recombivax,
Fendrix,
Fluzone,
Pdt,
Prevenar13,
Prevnar13,
Prp,
Menactra,
Pcv13,
Pneumovax,
Triapine,
Vaxigrip,
Ipv,
Repevax,
Flumist,
Pcv,
Flucelvax,
Prevenar
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use